Peregrine Ophthalmic
PrivateLast Round
Grant
Mar 9, 2015
Total Funding Raised
$3M
Company Overview
Peregrine Ophthalmic operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Grant round in March 2015.
Peregrine Ophthalmic is a biotechnology company that develops and delivers new solutions for the management of intraorbital and periorbital eye diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Peregrine Ophthalmic Comparables
Compare Peregrine Ophthalmic with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PolyActiva | 85% | |
| Mati Therapeutics | 77% | |
| Ocular Therapeutix Inc | 76% |
For institutional investors. Book with your work email.
Peregrine Ophthalmic Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 9, 2015
Secured $3M in grant funding.
- Aug 5, 2013
Completed a Seed funding round.
For institutional investors. Book with your work email.
Peregrine Ophthalmic Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Peregrine Ophthalmic's valuation, stock price, and market status.
Is Peregrine Ophthalmic a public or private company?
Peregrine Ophthalmic is a private company.
What is the current stock price of Peregrine Ophthalmic?
Peregrine Ophthalmic is a private company, so its shares have no public market price. Caplight tracks Peregrine Ophthalmic's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Peregrine Ophthalmic worth (valuation)?
Valuation information for Peregrine Ophthalmic is not publicly available.
Can I buy Peregrine Ophthalmic stock?
Peregrine Ophthalmic shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Peregrine Ophthalmic's last funding round?
Peregrine Ophthalmic's most recent funding round was Grant on March 9, 2015.
Who are the main investors in Peregrine Ophthalmic?
Investor information for Peregrine Ophthalmic is not publicly disclosed.
Will Peregrine Ophthalmic IPO soon?
No public IPO plans have been announced for Peregrine Ophthalmic.
How can I track Peregrine Ophthalmic secondary market activity?
Caplight tracks bids, offers, and trades in Peregrine Ophthalmic's shares on secondary markets.